DarioHealth (Nasdaq:DRIO) today announced real-world study data on the impact of managing diabetes and weight on a single digital platform. New York-based DarioHealth presented the published retrospective, real-world study observing its digital therapeutics platform at the Advanced Technologies and Treatments for Diabetes (ATTD) Conference in Barcelona.

Cytovia Therapeutics has found an “ISLE” to dock at in the choppy waters of biotech public markets. The natural killer (NK) cell startup is set to merge with a special purpose acquisition company (SPAC) to secure the cash to enter the clinic and try to get through to a data drop in 2024. Isleworth Healthcare Acquisition Corp. […]

A first healthy volunteer has been enrolled in a Phase 1 trial and given a first dose of PrimeC, an investigational combination therapy for people with amyotrophic lateral sclerosis (ALS), the treatment’s developer, NeuroSense Therapeutics, announced. The open-label Phase 1 trial (NCT05232461) is a pharmacokinetic study, or one that evaluates how a treatment moves into, through, and out of […]